| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000019916 |
| P698 | PubMed publication ID | 10325496 |
| P2093 | author name string | Moul JW | |
| P433 | issue | 5-6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 399-407 | |
| P577 | publication date | 1999-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | European Urology | Q15763991 |
| P1476 | title | Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy | |
| P478 | volume | 35 |
| Q40612662 | A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells |
| Q38782894 | Activin A regulates microRNAs and gene expression in LNCaP cells |
| Q35092971 | Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk |
| Q34214436 | Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials |
| Q34997082 | Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches |
| Q36085432 | Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining |
| Q35946094 | Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. |
| Q34193061 | Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis. |
| Q34626187 | Biotechnology and drug discovery--the future is here: a guide for the practicing urologist |
| Q34534087 | Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer |
| Q39427492 | CaM kinase control of AKT and LNCaP cell survival |
| Q73503577 | Clinical states in prostate cancer: toward a dynamic model of disease progression |
| Q26784351 | Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis |
| Q41839859 | Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies |
| Q47657085 | Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice. |
| Q34918676 | Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer |
| Q28731283 | Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides |
| Q52666493 | EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. |
| Q37709293 | Evaluation of apoptosis in cytologic specimens |
| Q33898844 | Facts and future lines of research in prostate cancer: concluding remarks |
| Q84125119 | Immunohistochemical verification of ductal differentiation in prostate cancer |
| Q35054043 | Immunopathological prognostic and predictive factors in prostate cancer |
| Q37141933 | Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study |
| Q36608461 | Lycopene |
| Q79443116 | Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue |
| Q36463994 | Molecular biology in prostate cancer |
| Q34214409 | New concepts in the pathology of prostatic epithelial carcinogenesis. |
| Q35763075 | Potential pathologic markers for prostate chemoprevention studies |
| Q39569708 | Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperativ |
| Q38709991 | Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis |
| Q34348248 | Prostate pathology: histologic and molecular perspectives. |
| Q74583989 | Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma |
| Q85178847 | Small molecules regulating apoptosis in the synovium in rheumatoid arthritis |
| Q35589386 | Squamous cell carcinoma of the conjunctiva: a series of 26 cases |
| Q33955367 | The role of angiogenesis in prostate and other urologic cancers: a review |
| Q37337735 | The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach |
| Q36397439 | Tissue print micropeel: a new technique for mapping tumor invasion in prostate cancer |
| Q52960162 | Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization. |
| Q81005174 | Utility of Bcl-2, P53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population |
| Q32005910 | Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression |
| Q44739308 | p53, Bcl-2 and AgNOR tissue markers: model approach in predicting prostate cancer characteristics. |
Search more.